Cite
APA Citation
Faehling, M., Schumann, C., Christopoulos, P., Hoffknecht, P., Alt, J., Horn, M., Eisenmann, S., Schlenska-Lange, A., Schütt, P., Steger, F., Brückl, W. M., & Christoph, D. C. (2020). durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP). Lung cancer, 150, 114–122. http://access.bl.uk/ark:/81055/vdc_100115294051.0x00004a